Medical Crossfire®: Advances in Atopic Dermatitis: A Multidisciplinary, Patient-Centered Approach to Addressing Unmet Therapeutic Needs

 


Release Date: December 28, 2017
Expiration Date: December 28, 2018
Media: Internet - based

Activity Overview

Atopic dermatitis (AD) is a multifactorial, multisystem disease, and interactions among biologic, genetic, environmental, and behavioral factors affect the course of the disease. Research suggests that the multidisciplinary care of people with AD may improve disease severity, quality of life, and adherence, especially for patients with refractory disease. This program reviews the importance of approaching this multisystem disease with multidisciplinary care that incorporates novel therapies, lifestyle measures, patient education, and patient-clinician shared decision-making.

Acknowledgement of Commercial Support

This activity is jointly provided by Global Education Group and Physicians’ Education Resource®, LLC.
 

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

Dermatologists, Allergists, Immunologists, Rheumatologists, and  Primary Care Physicians

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Explain how a multidisciplinary approach to care may improve patient outcomes in AD.
  • Elucidate the pathophysiology, signs and symptoms, and diagnostic criteria of AD.
  • Outline treatment plans for adults with moderate-to-severe AD based on current guideline recommendations for AD, the safety and efficacy of new and emerging treatment options, comorbidities, and patient quality of life.
  • Discuss how to engage patients in shared-decision making regarding their AD treatment options to improve adherence.

Moderator/Chair

Andrew F. Alexis, MD, MPH
Chairman, Department of Dermatology
Director, Skin of Color Center
Mount Sinai Saint Luke’s and Mount Sinai West
Associate Professor, Icahn School of Medicine, Mount Sinai
New York, New York

Disclosure: Grant/research support: Galderma; Consultant: Galderma, L’Oreal, Sanofi Genzyme, Regeneron

Faculty

Wendy Cantrell, DNP, CRNP
Assistant Professor
Manager, Clinical Research
UAB Department of Dermatology
Dermatology at the Whitaker Clinic
Birmingham, Alabama

Disclosure: Nothing to disclose
 
Anne Marie Ditto, MD
Associate Professor of Medicine
Division of Allergy-Immunology
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Disclosure: Stock/Shareholder: Pfizer

Patient Advocate

Julie Block, BA
President & CEO, National Eczema Association
San Rafael, California

Disclosure: Nothing to disclose

The staff of PER® have no relevant financial relationships with commercial interests to disclose.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physician’s Education Resource®, LLC (PER®).  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
 
This educational activity for 1.0  contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education

AANP Provider Logo - Updated 01-22-2013This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians’ Education Resource, LLC®. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.  Provider number: 1561024. This activity is approved for 1.0 contact hour, which includes 0 hour(s) of pharmacology.

Activity ID # 2414E
 
This activity was planned in accordance with AANP CE Standards and Policies.

Global Contact Information

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

To receive credit, participants must complete the online pretest, view the activity in its entirety, and complete the online posttest and activity evaluation form. After completing the online assessment tests, and completing the activity evaluation form, participants may request credit. All participants must request credit by December 29, 2018; CE credit will not be issued after this date.
 
 
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Physicians’ Education Resource, LLC® (PER®) do not recommend the use of any agent outside of the labeled indications. 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

System Requirements

PC
Microsoft Windows 2000 SE or above.
Flash Player Plugin (v7.0.1.9 or greater)
Internet Explorer (v5.5 or greater), or Firefox
Adobe Acrobat Reader*
MAC OS 10.2.8
Flash Player Plugin (v7.0.1.9 or greater)
Safari
Adobe Acrobat Reader*
Internet Explorer is not supported on the Macintosh
 
For questions about this Internet CE activity, please contact: ceinfo@permedical.com
Privacy Policy and Terms of Use Information: http://www.gotoper.com/privacy






Become a Member

Forgot Password?
Filter By